Skip to content
★ Sign in to follow
PH

Paul Hayes

CFO
Consort Medical PLC
Total declarations
21
Company
1
▲ Purchases (2 ops.)
€84k
▼ Sales (0 ops.)
—

Latest filing published 06 Feb 2020 for Consort Medical PLC.

Filing timeline

BuySale
Paul Hayes

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Paul Hayes: trading record in brief

This profile gathers the share dealings of Paul Hayes in Consort Medical PLC. Between 20 June 2017 and 4 February 2020, the trades on record add up to 21 filings.

Purchases make up the whole of the open-market record (2 purchases, €84k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 19 share grants.

The latest filing, published on 6 February 2020, reports a share grant in Consort Medical PLC. The latest purchase dates back some time: it was published 2,894 days ago, on 6 December 2018. Filings reach the RNS (LSE) feed a median of 2 days after the trade. The regulation allows three business days to notify a trade (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to Paul Hayes

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total
  • ◆
    CFOExecutivesConsort Medical PLC
    0FCA-NSM
    293,697 sharesExercise of options: Off market Sale of share under offer: London Stock ExchangeISIN GB0000946276FCA-NSM:LSE20200206163125_3486886_20200331164939827_5995-1
  • ◆
    CFOExecutivesConsort Medical PLC
    148 GBP19FCA-NSM
    14 shares@ £10.54790.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191211093201_14344236_20200326185105895_19266-1
  • ◆
    CFOExecutivesConsort Medical PLC
    147 GBP19FCA-NSM
    20 shares@ £7.360.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191111112348_14302817_20200326185148287_22020-1
  • ◆
    CFOExecutivesConsort Medical PLC
    52 GBP19FCA-NSM
    7 shares@ £7.40860.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191101070006_14290011_20200326185148836_32421-1
  • ◆
    CFOExecutivesConsort Medical PLC
    153 GBP24FCA-NSM
    21 shares@ £7.293851.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191009101440_14259719_20200326185154548_26986-1
  • ◆
    CFOExecutivesConsort Medical PLC
    147 GBP24FCA-NSM
    19 shares@ £7.731148.9% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190913090323_14225783_20200326185204416_24361-1
  • ◆
    CFOExecutivesConsort Medical PLC
    0FCA-NSM
    67,150 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190829120613_14206597_20200326185055315_3003-1
  • ◆
    CFOExecutivesConsort Medical PLC
    150 GBP19FCA-NSM
    20 shares@ £7.520.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190812095436_14185124_20200326185058006_28632-1
  • ◆
    CFOExecutivesConsort Medical PLC
    145 GBP19FCA-NSM
    20 shares@ £7.2570.5% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181211091157_13899103_20200330111408224_9401-1
  • ▲
    Chief Financial OfficerExecutivesConsort Medical PLC
    30,452 GBP27FCA-NSM
    4,000 shares@ £7.61397.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181206171835_13894840_20200330111408049_5889
    Canonical exit: 5 Mar 2019 (T+90)
  • ◆
    CFOExecutivesConsort Medical PLC
    157 GBP19FCA-NSM
    14 shares@ £11.19070.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181108154931_13860676_20200330111438836_22440-1
  • ◆
    CFOExecutivesConsort Medical PLC
    34 GBP19FCA-NSM
    3 shares@ £11.360.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181031111751_13849534_20200330111442171_586-1
  • ◆
    CFOExecutivesConsort Medical PLC
    149 GBP19FCA-NSM
    13 shares@ £11.42540.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20181010142409_13823796_20200330111443439_18950-1
  • ◆
    CFOExecutivesConsort Medical PLC
    146 GBP19FCA-NSM
    12 shares@ £12.200.5% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20180910070007_13783863_20200330111447118_17626-1
  • ◆
    CFOExecutivesConsort Medical PLC
    149 GBP19FCA-NSM
    13 shares@ £11.460.5% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20180809070014_13749058_20200330111404481_16786-1
  • ◆
    CFOExecutivesConsort Medical PLC
    153 GBP19FCA-NSM
    13 shares@ £11.760.5% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20180711161657_13714481_20200330111420626_17076-1
  • ◆
    CFOExecutivesConsort Medical PLC
    141 GBP19FCA-NSM
    12 shares@ £11.75580.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20171211084643_13460437_20200330131507515_7690-1
  • ◆
    CFOExecutivesConsort Medical PLC
    151 GBP19FCA-NSM
    14 shares@ £10.790.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20171109112351_13426299_20200330131534313_7989-1
  • ◆
    CFOExecutivesConsort Medical PLC
    152 GBP19FCA-NSM
    14 shares@ £10.87860.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20171011141056_13393581_20200330131537683_7567-1
  • ◆
    CFOExecutivesConsort Medical PLC
    152 GBP19FCA-NSM
    14 shares@ £10.87860.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20170911171524_13358928_20200330131540201_7102-1
  • ▲
    Chief Financial OfficerExecutivesConsort Medical PLC
    43,778 GBP25FCA-NSM
    4,000 shares@ £10.944558.2% of flowLondon Stock Exchange Main Market (XLon)ISIN GB0000946276FCA-NSM:LSE20170621121028_13268449_20200330131522625_17154
    Canonical exit: 18 Sept 2017 (T+90)

21 of 21 declarations